Title : Sodium butyrate enhances the growth inhibitory effect of sunitinib in human renal cell carcinoma cells.

Pub. Date : 2017 Jul

PMID : 28693255






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Sunitinib (SU) is a small molecule that inhibits the receptor tyrosine kinase (RTK) signaling pathway, and has been clinically used to treat advanced renal cell carcinoma (RCC). Sunitinib ret proto-oncogene Homo sapiens
2 Sunitinib (SU) is a small molecule that inhibits the receptor tyrosine kinase (RTK) signaling pathway, and has been clinically used to treat advanced renal cell carcinoma (RCC). Sunitinib ret proto-oncogene Homo sapiens
3 Sunitinib (SU) is a small molecule that inhibits the receptor tyrosine kinase (RTK) signaling pathway, and has been clinically used to treat advanced renal cell carcinoma (RCC). Sunitinib ret proto-oncogene Homo sapiens
4 Sunitinib (SU) is a small molecule that inhibits the receptor tyrosine kinase (RTK) signaling pathway, and has been clinically used to treat advanced renal cell carcinoma (RCC). Sunitinib ret proto-oncogene Homo sapiens